Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol TGFB3 contributors: mct - updated : 27-09-2021
HGNC name transforming growth factor, beta 3
HGNC id 11769
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • N terminal LAP (latency associated peptide)
  • prodomains of TGFB1 and TGFB3 contain an RGD motif that is recognized by alpha5 integrins
  • EGF repeats
  • a C terminal TGFB sequence
  • mono polymer homomer , dimer
    HOMOLOGY
    Homologene
    FAMILY TGF beta superfamily
    CATEGORY signaling cytokine growth factor
    SUBCELLULAR LOCALIZATION extracellular
        intracellular
    intracellular,cytoplasm
    intracellular,nucleus
    basic FUNCTION
  • involved in embryogenesis and cell differentiation
  • role in the etiology of Cleft lip/palate among the central European population if the risk allele is inherited from the father
  • may actually play a protective role against tumourigenesis in a range of tissues including the skin, breast, oral and gastric mucosa
  • TGFB3 signaling is crucial for proper differentiation and morphogenesis of neural crest-derived cells in eye structures
  • MSX1 and TGFB3 signaling is crucial for proper differentiation and morphogenesis of neural crest-derived cells in eye structures
  • TGFB3 signaling cascade regulates the FasL-Fas-caspase extrinsic apoptosis pathway and is essential for palatal fusion during craniofacial development
  • persistent TGFB3 activation increased ROS levels in a NOX4-dependent pathway and subsequently induced autophagy as well as MUC5AC expression in the epithelial cells
  • can effectively promote the transformation process from fat stem cells to chondrocytes, thus promoting chondrogenesis
  • mainly plays a role through WNT5A/CTNNB, promoting human fat stem cell growing into the cartilage
  • TGFB2 and TGFB3 may play a pathological role in fibrosis
  • CELLULAR PROCESS cell life, proliferation/growth
    cell organization/biogenesis
    PHYSIOLOGICAL PROCESS development
    PATHWAY
    metabolism
    signaling signal transduction
    via the SMAD (MADH2 or MADH3-MADH4) complex
    a component forming a small latent complex by disulfide bonding between TGFB dimer and the propeptide dimer TGF-beta 1 latency associated prolypeptide (LAP)
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • great interaction between TGFB1 and TGFB3 in the developing palate, confirming that TGFB3 has a more active role in midline epithelial seam cell death than TGFB1
  • interacting with CDC42 (CDC42 is a crucial regulatory component in the TGFB3-mediated cascade of events that leads to the disruption of the tight junction fibrils above the preleptotene spermatocytes to facilitate their transit (
  • interacting with FOXE1 (role of FOXE1 in controlling the expression of MSX1 and TGFB3 relevant in craniofacial development)
  • interacting with Wnt/CTNNB (essential role for Wnt/CTNNB signaling in the epithelial component at the step of palate fusion during palate development by controlling the expression of TGFB3 in the medial edge epithelium (MEE))
  • IRF6 is involved in TGFB3-mediated palatal fusion
  • cell & other epithelial-mesenchymal interactions
    REGULATION
    induced by SNAI1, SNAI2 (SNAI1 and SNAI2 promote formation of beta-catenin-T-cell factor (TCF)-4 transcription complexes that bind to the promoter of the TGFB3 gene to increase its transcription)
    ASSOCIATED DISORDERS
    corresponding disease(s) ARVD1 , LDS5
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in chondrosarcomas
    tumoral     --over  
    in Glioblastoma
    Susceptibility
  • to nonsyndromic cleft lip with or without cleft palate
  • to ossification of the posterior longitudinal ligament of the spine
  • to male infertility
  • to gestational diabetes mellitus (GDM)
  • Variant & Polymorphism SNP
  • increasing the risk of ossification of the posterior longitudinal ligament of the spine
  • polymorphisms increasing the risk of nonsyndromic cleft lip with or without cleft palate
  • heterozygous rs2284792 AG genotype was associated with increased odds for infertility
  • AA and AG genotype of TGFB3 rs2284792 polymorphism may be significantly associated with increased risk of GDM
  • Candidate gene
  • to nonsyndromic cleft lip with or without cleft palate
  • Marker
    Therapy target
    SystemTypeDisorderPubmed
    cancerbrainglioma/neuroblstoma
    targeting TGFB3 may represent a promising strategy interfering with aberrant TGFB signaling in glioblastoma
    ANIMAL & CELL MODELS
  • abnormal limb development and cleft palate in mice lacking TGFB3
  • Tgf-beta3 null mutant palates of two strains of mice (C57/BL/6J (C57), and MF1) that develop cleft palates of different severity